Combined TNF-α -308 (rs1800629) genotype and TyG index for identifying metabolic syndrome in a Vietnamese adult cohort
Nội dung chính của bài viết
Tóm tắt
The triglyceride-glucose (TyG) index is a robust surrogate for insulin resistance. This study evaluated the diagnostic and discriminative utility of combining the TyG index with the TNF-α -308G>A (rs1800629) genotype for early identification of Metabolic Syndrome (MetS) in a Vietnamese cohort, accounting for Metabolic Dysfunction-Associated Steatotic Liver Disease (MAFLD). This cross-sectional analysis included 311 medical and administrative staff. MetS was defined by harmonized criteria. The TyG index and TNF-α -308 genotypes were analyzed using multivariable logistic regression and Area Under the Receiver Operating Characteristic (AUC-ROC) curves, with stratification by MAFLD status. MetS prevalence was 17.4%. The TyG index was a highly significant independent discriminator of MetS (Adjusted OR = 59.73, p < 0.001). The TNF-α -308 A-allele carrier status did not significantly associate with MetS (Adjusted OR = 0.26, p = 0.120). The combined model yielded an AUC of 0.955 versus 0.952 for the reference model (ΔAUC = +0.003). While incremental AUC was slightly higher in the MAFLD subgroup (ΔAUC = +0.014), the synergistic effect was not statistically significant. The TyG index demonstrates excellent diagnostic utility for MetS. However, incorporating the TNF-α -308 genotype does not provide clinically meaningful incremental discriminative value in this population.
Chi tiết bài viết
Từ khóa
Metabolic Syndrome, TyG index, TNF-α -308, MAFLD, discriminative utility
Tài liệu tham khảo
2. Habibullah M, Jemmieh K, Ouda A, Haider MZ, Malki MI, Elzouki AN. Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies. Front Med (Lausanne). 2024; 11:1291501. doi:10.3389/fmed.2024.1291501.
3. Avagimyan A, Pogosova N, Fogacci F, et al. Triglyceride-glucose index (TyG) as a novel biomarker in the era of cardiometabolic medicine. Int J Cardiol. 2025; 418: 132663. doi:https://doi.org/10.1016/j.ijcard.2024.132663.
4. Wan H, Cao H, Ning P. Superiority of the triglyceride glucose index over the homeostasis model in predicting metabolic syndrome based on NHANES data analysis. Sci Rep. 2024; 14(1): 15499. doi:10.1038/s41598-024-66692-9.
5. Dwi Astarini F, Ratnasari N, Wasityastuti W. Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative Review. Iran Biomed J. 2022; 26(4): 252-268. doi:10.52547/ibj.3647.
6. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 1997; 94(7): 3195-3199. doi:10.1073/pnas.94.7.3195.
7. Ghareeb D, Abdelazem AS, Hussein EM, Al-Karamany AS. Association of TNF-α-308 G>A (rs1800629) polymorphism with susceptibility of metabolic syndrome. J Diabetes Metab Disord. 2022; 21(2): 1197-1203. doi:10.1007/s40200-022-01059-z.
8. Hamedi-Shahraki S, Klisic A, Amirkhizi F, Mercantepe F. Association of the triglyceride-glucose index with inflammatory markers and dysregulation of adipokines in patients with metabolic syndrome. BMC Endocr Disord. 2026; 26(1): 44. doi:10.1186/s12902-025-02142-5.
9. D’Elia L, Masulli M, Barbato A, et al. Triglyceride-Glucose Index, HOMA Index and metabolic syndrome in a sample of adult men. Minerva Endocrinol (Torino). 2024; 49(3): 349-356. doi:10.23736/S2724-6507.24.04240-2.
10. Taha O, Abdallah L, Erfan A, Elsharaby R, El Amrousy D. The triglyceride glucose index as a biomarker for different glucose disorders in overweight and obese children and adolescents. Eur J Pediatr. 2025; 184(2): 118. doi:10.1007/s00431-024-05940-0.
11. Wang D, He L, Zhang X. -308G/A polymorphism of tumor necrosis factor alpha (TNF-α) gene and metabolic syndrome susceptibility: a meta-analysis. Sci Rep. 2021; 11(1): 3840. doi:10.1038/s41598-021-83321-x.
12. Nguyen H, Le D, Ho T, et al. TNF-α rs1800629 Polymorphism in Vietnamese COPD Patients: Exploratory Evidence for Recessive Protective Association and Clinical Correlates. Appl Clin Genet. 2026; 19: 55-70. doi:10.2147/TACG.S586977.
13. Zhang X, et al. Triglyceride-glucose index demonstrates false-positive association with cardiometabolic multimorbidity progression. Medicine. 2026; 105(7): e41567.